Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer

被引:119
|
作者
Healy, L. A. [1 ,2 ]
Ryan, A. M. [1 ,2 ]
Carroll, P. [2 ,3 ]
Ennis, D. [2 ,3 ]
Crowley, V. [2 ,4 ]
Boyle, T. [2 ,3 ]
Kennedy, M. J. [2 ,5 ]
Connolly, E. [2 ,3 ]
Reynolds, J. V. [2 ,3 ]
机构
[1] St James Hosp, Dept Clin Nutr, Dublin 8, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Surg, Dublin 8, Ireland
[4] St James Hosp, Dept Clin Chem, Dublin 8, Ireland
[5] St James Hosp, Acad Unit Clin & Med Oncol, Dublin 8, Ireland
关键词
Breast cancer; metabolic syndrome; obesity; postmenopausal; tumour pathology; BODY-MASS INDEX; RECEPTOR EXPRESSION; SEX-HORMONES; RISK-FACTOR; C-PEPTIDE; WOMEN; SIZE; POPULATION; PREVALENCE; MORTALITY;
D O I
10.1016/j.clon.2010.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Obesity is associated with both an increased risk of postmenopausal breast cancer and increased mortality rates. The mechanism is unclear, and central (visceral) obesity, insulin resistance, altered sex steroids and altered adipokines are mooted as possible factors. These features may cluster in the so-called metabolic syndrome. The relevance of metabolic syndrome to the biology of breast cancer is unknown, and this was the focus of the present study. Materials and methods: All postmenopausal women with newly diagnosed breast cancer (n = 105) were recruited. A detailed clinical history was carried out, as well as a body composition analysis, metabolic screen and measurement of adipokines and inflammatory markers. Results: The median age was 68 years (40-94 years) and the mean body mass index was 28.3 +/- 5.2 kg/m(2), with 87% of patients centrally obese. Metabolic syndrome was diagnosed in 39% of patients, and was significantly associated with central obesity (P < 0.005) and increased inflammation, with C-reactive protein levels doubling in metabolic syndrome patients compared with non-metabolic syndrome patients (10.3 vs 5.8 mg/l; P = 0.084). Patients with a later pathological stage (II-IV) were significantly more likely to be obese (P = 0.007), centrally obese (P = 0.009), hyperglycaemic (P = 0.047) and hyperinsulinaemic (P = 0.026); 51% had metabolic syndrome compared with 12% for early stage disease. Patients with node-positive disease were significantly more likely to be hyperinsulaemic (P = 0.030) and have metabolic syndrome (P = 0.028) than patients with node-negative disease. Discussion: The data suggest that metabolic syndrome and central obesity are common in postmenopausal breast cancer patients, and that metabolic syndrome may be associated with a more aggressive tumour biology. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 50 条
  • [1] Metabolic syndrome and leptin are associated with adverse pathological features in male colorectal cancer patients
    Healy, L. A.
    Howard, J. M.
    Ryan, A. M.
    Beddy, P.
    Mehigan, B.
    Stephens, R.
    Reynolds, J. V.
    COLORECTAL DISEASE, 2012, 14 (02) : 157 - 165
  • [2] Metabolic syndrome and the risk of breast cancer among postmenopausal women in north-west China
    Wang, M.
    Cheng, N.
    Zheng, S.
    Wang, D.
    Hu, X.
    Ren, X.
    Pei, H.
    Ma, H.
    Mu, H.
    Bai, Y.
    CLIMACTERIC, 2015, 18 (06) : 852 - 858
  • [3] Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER plus breast cancer
    Bergman, Riley
    Berko, Yvonne A.
    Sanchez, Violeta
    Sanders, Melinda E.
    Gonzalez-Ericsson, Paula, I
    Arteaga, Carlos L.
    Rexer, Brent N.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) : 307 - 317
  • [4] Relative Contribution of Metabolic Syndrome Components in Relation to Obesity and Insulin Resistance in Postmenopausal Osteoporosis
    Greere, Daniela
    Grigorescu, Florin
    Manda, Dana
    Voicu, Gabriela
    Lautier, Corinne
    Nitu, Ileana
    Poiana, Catalina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [5] The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients
    Can, A.
    Alacacioglu, A.
    Kucukzeybek, Y.
    Erten, C.
    Cokmert, S.
    Demir, L.
    Dirican, A.
    Bayoglu, I. Vedat
    Akyol, M.
    Aslan, F.
    Tarhan, M. Oktay
    JOURNAL OF BUON, 2013, 18 (04): : 845 - 850
  • [6] A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer
    Weichhaus, Michael
    Broom, John
    Wahle, Klaus
    Bermano, Giovanna
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (02) : 745 - 752
  • [7] Obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents
    Nasreddine, Lara
    Naja, Farah
    Tabet, Maya
    Habbal, Mohammad-Zuheir
    El-Aily, Aida
    Haikal, Chrystel
    Sidani, Samira
    Adra, Nada
    Hwalla, Nahla
    ANNALS OF HUMAN BIOLOGY, 2012, 39 (02) : 122 - 128
  • [8] Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome
    Orsatti, Claudio Lera
    Orsatti, Fabio Lera
    Bezerra, Thaiz Geovana
    Quevedo, Ana
    Nahas, Eliana Aguiar Petri
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (09) : 765 - 770
  • [9] Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver
    Sung, Ki-Chul
    Lee, Mi Yeon
    Kim, Young-Hwan
    Huh, Ji-Hye
    Kim, Jang-Young
    Wild, Sarah H.
    Byrne, Christopher D.
    ATHEROSCLEROSIS, 2018, 275 : 50 - 57
  • [10] High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome
    Goodwin, Pamela J.
    Ennis, Marguerite
    Bahl, Mala
    Fantus, I. George
    Pritchard, Kathleen I.
    Trudeau, Maureen E.
    Koo, Jarley
    Hood, Nicky
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 517 - 525